investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Molecular Mediators of Pancreatic Cancer Invasion and Progression
Keping Xie
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Liwei Wang
Shanghai Jiao Tong University
Shanghai, China
Keping Xie
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
S Perwez Hussain
Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer
Pancreas
Pathology
Eric Collisson
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
Pancreas
Pathology
Eric Collisson
Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis
Pancreas
Pathology
Aliye Uc
INSPPIRE to Study Pediatric Chronic Pancreatitis
Pancreas
Pathology
Donald J Buchsbaum
UAB / UMN SPORE in Pancreatic Cancer
Pancreas
Pathology
Peter J Allen
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
Pancreas
Pathology
Robert M Straubinger
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
Pancreas
Pathology
Anthony G Letai
Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer
Pancreas
Pathology
S P Hussain
Integrative Molecular Profiling of Human Pancreatic Cancer
Pancreas
Pathology
